Lactobacillus rhamnosus - the world´s most documented probiotic

Lactobacillus rhamnosus is a bacteria that exists naturally in the body, primarily in the intestines. Lactobacillus rhamnosus helps maintain a balance of "good bacteria" needed to prevent the growth of harmful bacteria in the stomach and intestines.

Lactobacillus rhamnosus GG, known as LGG^®, originates from the human intestinal flora and was discovered by Professors Gorbach and Goldin – giving name to the strain. The strain has been used worldwide for more than 20 years as an ingredient in food and food supplements with no reported side effects.

Lactobacillus rhamnosus has been used to treat or prevent diarrhea caused by rotavirus and other viral illnesses in babies and children. This product has also been used to treat diarrhea that can occur while taking antibiotics or while traveling to foreign countries ("traveler`s diarrhea").

Lactobacillus rhamnosus may be taken with or without food.

Lactobacillus rhamnosus primarily exists in the human digestive system, but can also be found in the human urinary and genital tracts (Lee, 2009). It is also used in various food products, usually dairy products such as yogurt, fermented milk, pasteurized milk, and semi-hard cheese.

It is one of the most widely studied bacterial strains due to its use in probiotics and its lack of pathogenicity.

Lactobacillus rhamnosus has generally been shown to be beneficial in its use in probiotics for general digestive health and gastrointestinal diseases due to its ability to encode for proteins related to carbohydrate transport and metabolism and its ability adhere to gut and intestinal mucosa.

Furthermore, the use of Lactobacillus rhamnosus has proven to be safe among a variety of gender, age, and health groups.

Mixed results for the studies of Lactobacillus rhamnosus in the treatment and prevention of atopic dermatitis indicate that further research needs to be conducted in this area. However, the molecular mechanisms of Lactobacillus rhamnosus and its relation to atopic dermatitis indicate a promising future for its use in probiotics.

Emerging areas of study for the use of Lactobacillus rhamnosus in probiotics include the treatment of joint symptoms and diabetes. There have animal studies and one human trial that suggest that Lactobacillus rhamnosus  may alleviate joint symptoms (Goldin and Gorbach, 2008).

Another study indicated that Lactobacillus rhamnosus could lower levels of blood hemoglobin A1c and improve glucose tolerance for animals with diabetes (Goldin and Gorbach, 2008). While research in this area has been new and limited, Lactobacillus rhamnosus has been shown to treat and prevent diseases and infections that treat a variety of recurring and problematic diseases. 

Lactobacillus rhamnosus is a refreshing example of a natural, prevalent drug used for probiotics among the popular discussion of harmful microbes and antibiotics.

 

 

Goldin, B. R., and S. L. Gorbach. "Clinical indications for probiotics: an overview." Clinical Infectious Diseases 46.Supplement 2 (2008): S96-S100.

Kategorier og register